20.10新台幣0.1(0.5%)
2024/12/19更新
績效 / 1月1.81%
3月9.46%
1年9.24%
晨星評等 - 1.現金5.99%
- 2.股票14.88%
- 3.債券0.04%
- 4.其他79.09%
- 1.美國81.71%
- 2.歐洲不包含歐元區10.89%
- 3.英國2.19%
- 4.新興亞洲1.02%
- 5.日本0.56%
- 1.健康護理75.27%
- 2.工業6.23%
- 3.科技6.01%
- 4.周期性消費4.99%
- 5.電訊服務3.27%
- 6.公用0.69%
- 7.防守性消費0.04%
- 8.房地產0.04%
- 9.金融服務0.04%
- 1.Eli Lilly and Co9.29%
- 2.SPDR® S&P Biotech ETF8.02%
- 3.Novo Nordisk AS Class B6.78%
- 4.Intuitive Surgical Inc5.32%
- 5.UnitedHealth Group Inc4.95%
- 6.Amgen Inc4.58%
- 7.HCA Healthcare Inc3.99%
- 8.Boston Scientific Corp3.97%
- 9.Universal Health Services Inc Class B3.10%
- 10.Vertex Pharmaceuticals Inc2.99%
- 1.現金5.99%
- 2.股票14.88%
- 3.債券0.04%
- 4.其他79.09%
- 1.健康護理75.27%
- 2.工業6.23%
- 3.科技6.01%
- 4.周期性消費4.99%
- 5.電訊服務3.27%
- 6.公用0.69%
- 7.防守性消費0.04%
- 8.房地產0.04%
- 9.金融服務0.04%
- 1.美國81.71%
- 2.歐洲不包含歐元區10.89%
- 3.英國2.19%
- 4.新興亞洲1.02%
- 5.日本0.56%
- 1.Eli Lilly and Co9.29%
- 2.SPDR® S&P Biotech ETF8.02%
- 3.Novo Nordisk AS Class B6.78%
- 4.Intuitive Surgical Inc5.32%
- 5.UnitedHealth Group Inc4.95%
- 6.Amgen Inc4.58%
- 7.HCA Healthcare Inc3.99%
- 8.Boston Scientific Corp3.97%
- 9.Universal Health Services Inc Class B3.10%
- 10.Vertex Pharmaceuticals Inc2.99%